Title:Expanding Horizon of Cervical Cancer Screening by Involving Antenatal Patients
Authors: Dr Sangeeta Pahwa, Dr Rimmi Mahajan*, Dr Madhu Nagpal1 Dr Amanbeer
DOI: https://dx.doi.org/10.18535/jmscr/v4i12.80
Abstract
Objective: To study the risk factors, types, incidence and prevalence of cervical cytopathological features that may be present in pregnant women on Pap Smear and expand cervical screening through Pap smear in pregnant females.
Materials and Methods: Three hundred antenatal women attending the antenatal outpatient department were subjected to a Pap smear. History was taken and survey conducted as per a proforma in order to obtain data regarding participants’ socio-demographic characteristics, gynecological, obstetrical history, habits, and their knowledge, if any, of pap tests and cervical cancer.
Results: There were 168 abnormal Pap smears in this study out of the 300 taken and analyzed. The prevalence of abnormal smears was 56%. The abnormal smears included inflammation (50.67%), monilial pathology (3.33%), trichomonas infection (2%). No epithelial cell abnormality, such as ASCUS, LSIL or HSIL, was seen.
Conclusions: A significant number of pregnant women have abnormal smears. A screening programme during pregnancy may be ideally be suited to the population type as in India, as antenatal visits are often the first point of contact with a gynaecologist in developing countries.
Keywords: Pap Smear, cervical cancer, antenatal, pregnancy, cervical screening.
References
1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of Cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127:2893-917.
2. Guidelines for cervical cancer screening. GOI WHO Collaboration program. 2004 - 2005.
3. Winer RL, Hughes JP, Feng Q, O’Reilly S, Kiviat NB, Holmes KK et al. Condom use and the risk of genital human papillomavirus infection in young women. N Engl J Med. 2006;354:2645–54.
4. Ferenczy A, Franco E. Cervical-cancer screening beyond the year 2000. Lancet Oncol. 20012:27–32.
5. Massad LS, Einstein MH, Huh WK, Katki HA, Kinney WK, Schiffman M et al. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. Obstet Gynecol. 2013;121:829-46.
6. Morice P, Uzan C, Gouy S, Versharaegen C, Haie-Meder C. Gynaecological cancers in pregnancy. Lancet. 2012;379:558-69.
7. Summary report on HPV and cervical cancer statistics in India 2007.WHO/ICO Information Centre on HPV and Cervical Cancer .Available from: http://www.who.int/hpvcentre. Last assessed on May 1, 2008.
8. Mattila ML, Rautava P, Sillanpaa M, Paunio P. Caries in five-year-old children and associations with family-related factors. Journal of Dental Research 2000;79(3):875-81.
9. Hofer TP, Katz SJ. Health behaviors among women in the United States and Ontario: The effect of use of preventive care. American Journal of Public Health. 1996;86(12):1755-9.
10. Dell DL, Chen H, Ahmad F, Stewart DE. Knowledge about human papillomavirus among adolescents. Obstetrics & Gynecology. 2000;96(5):653-56.
11. Mays RM, Zimet GD, Winston Y . Human papillomavirus, genital warts, pap smears, and cervical cancer: Knowledge and beliefs of adolescent and adult women. Health Care for Women International 2000;21:361-74.
12. Vural E, Gonenc L, Aka N. Antenatal kontrollerde pap smear taramasıvesonu-cları. Türkiye Aile Hekimligi Dergisi. 2004;8:111-5.
13. Diallo MO, Ettiègne-Traoré V, Maran M, Kouadio J, Brattegaard K, Makke A et al. Sexually transmitted and human immunodeficiency virus infections in women attending an antenatal clinic in Abidjan, Cote d'Ivoire. Int J STD AIDS. 1997;8:636-8.
14. Ayres de Campos D, Nogueira A, Magalhães F, Bayer P, Monteiro J, Lameirão A et al. Inflammatory smears in cervicovaginal cytology: A finding meaning infection? Acta Med Port. 1997;10:637-41.
15. Lanouette JM, Puder KS, Berry SM, Bryant DR, Dombrowski MP. Is inflammation on Papanicolaou smear a risk factor for preterm delivery? Fetal DiagnTher. 1997;12:244-7.
16. Bedrossian UK, Fairfax MR, Ayers M. Pap smear follow-up of mucopurulent exudate as a prognostic indicator of a negative pregnancy outcome. Diagn Cytopathol. 1999;21:4-6
17. Ngaojaruwong N, Vuthiwong C, Punpuckdeekoon P, Thongsorn N. Prevalence of abnormal Papanicolaou smear in pregnant women at Phramongkutklao Hospital. Thai J Obstet Gynaecol. 2008;16:179-85.
18. Seda J, Avellanet Y, Roca FJ, Hernandez E, Umpierre SA, Romaguera J. Risk factors for abnormal cervical cytology in pregnant women attending the high-risk obstetrics clinic at the University Hospital in San Juan, Puerto Rico. P R Health Sci J. 2011;30:14-7.
19. Ozgun G, Aydogdu G. Distribution of cervical lesions & relation between age and parity rates in the Mardin province. Turk Patoloji Derg. 2013;29:46-50.
20. Remschmidt C, Kaufmann AM, Hagemann I, Vartazarova E, Wichmann O, Deleré Y. Risk factors for cervical human papillomavirus infection & high grade intra epithelial lesion in women aged 20 to 31 years in Germany. Int J Gynaecol Cancer. 2013;23:519-26.
21. Daly SF, Doyle M, English J, Turner M, Clinch J, Prendiville W. Can the number of cigarettes smoked predict high-grade cervical intraepithelial neoplasia among women with mildly abnormal cervical smears? Am J Obstet Gynecol. 1998 Aug;179(2):399–402.
22. Ajah LO, Chigbu CO, Ozumba BC, Oguanuo TC, Ezeonu PO. Is there any association between hormonal contraceptives and cervical neoplasia in a poor Nigerian setting? Onco Targets Ther. 2015;9:1887-92.